TeVido Biodevices is applying 3D bioprinting technology invented by the firm to advance reconstruction surgery options for patients with cancer and other conditions. Using the firm's technology, human cells and scaffolds (supporting material) can be spatially positioned in 3D space to elicit a desired response. The firm subequently worked on forming adipose (fat) grafts that will not only fill the void created by solid tumor removal, but also hold their shape and structure over time. Opting to engage this capability initially in breast cancer reconstruction, TeVido worked on developing innovative 3D printed custom breast implants, from a woman's own cells, for reconstruction after cancer treatment. By using a patientâs own cells, a further objective was to reduce/eliminate need for anti-rejection drugs. Expanding capability from this initial type of surgery to others suffering disfigurement in addition to reconstruction, TeVido technology c/would be applicable across a wide range of wound healing and cosmetic surgery(ies)
